Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
---|
02/05/2004 | US20040023996 Methods and compositions utilizing quinazolinones |
02/05/2004 | US20040023968 Phthalazinone derivatives |
02/05/2004 | US20040023966 Agricultural/ horticultural fungicides containing said derivatives as the active ingredients. |
02/05/2004 | US20040023945 Cyclic amp-specific phosphodiesterase inhibitors |
02/05/2004 | US20040023805 Substituted phenyluracils |
02/05/2004 | DE10234876A1 4-Trifluormethylpyrazolyl substituierte Pyridine und Pyrimidine 4-substituted pyridines and pyrimidines Trifluormethylpyrazolyl |
02/05/2004 | DE10234058A1 Neue substituierte Benzoesäureamide, deren Herstellung und deren Verwendung als Arzneimittel New substituted benzamides, their preparation and their use as medicaments |
02/05/2004 | DE10148618A1 Substituierte N-(1,4,5,6-Tetrahydro-cyclopentapyrazol-3-yl)-Derivate, deren Herstellung und Verwendung als Arzneimittel Substituted N- (1,4,5,6-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their preparation and use as medicaments |
02/05/2004 | CA2494102A1 Antagonist of melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredient |
02/05/2004 | CA2493924A1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect |
02/05/2004 | CA2493309A1 Site-specific labelling of proteins using cyanine dye reporters |
02/05/2004 | CA2492305A1 Aryl substituted benzimidazoles and their use as sodium channel blockers |
02/04/2004 | EP1386915A1 Azole compounds, process for preparation of the same and use thereof |
02/04/2004 | EP1386913A1 Pyrrole derivative |
02/04/2004 | EP1386912A1 Cyclic amidine derivative |
02/04/2004 | EP1386317A1 Optical data carrier that contains a cyanine dye as the light-absorbing compound in the information layer |
02/04/2004 | EP1385848A2 Phtalazinones derivatives useful as pde4/7 inhibitors |
02/04/2004 | EP1385845A1 N-aroyl cyclic amines |
02/04/2004 | EP1385842A1 Heterocyclyloxy-, -thioxy- and -aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
02/04/2004 | EP1385840A1 Sulfonamides |
02/04/2004 | EP1385838A1 Piperazino-derivatives and their use as pde4 inhibitor |
02/04/2004 | EP1385833A1 Triazinyl amide derivatives as angiogenesis inhibitors |
02/04/2004 | EP1385832A2 Production of tertiary amines by reductive amination |
02/04/2004 | EP1385828A1 Compounds of the family of 3-alkyl-(4,5 dipheny-imidazol-1-yl) and their use as soothing agents |
02/04/2004 | EP1385823A1 Novel guanidino compounds |
02/04/2004 | EP1385507A1 Sulfonamides |
02/04/2004 | EP0684816B1 5-ht2 receptor antagonists for treating venous conditions |
02/04/2004 | CN1473161A Pyrazole compounds as protein kinase inhibitors |
02/04/2004 | CN1473160A Indole derivatives as medicinal compositions for antifungal and/or antiparasitic agents |
02/04/2004 | CN1473156A Pyrimidine derivatives and their use as neuropeptide y receptor ligands |
02/04/2004 | CN1473154A Phthalazinone derivatives |
02/04/2004 | CN1473153A Hetero-anellated ortho-aminophenols |
02/03/2004 | US6686383 Treatment of diabetic nephropathy with a biphenyl-4-yl)alkyl-1h-benzimidazole compounds |
02/03/2004 | US6686372 Selective β3 adrenergic agonists |
02/03/2004 | US6686369 α-hydrdroxylic acid derivatives, their production and use |
02/03/2004 | US6686368 Inhibitors of factor Xa |
02/03/2004 | US6686362 Indolinone derivatives |
02/03/2004 | US6686353 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
02/03/2004 | US6686350 Cell adhesion inhibitors |
02/03/2004 | CA2092510C Crystalline forms of endo-2,3-dihydro-n-(8-methyl-8-azabicyclo-[3.2.1.]oct-3-yl)-2-oxo-1h-benzimidazole-1-carboxamide hydrochloride monohydrate and of endo-3 ethyl-2,3-dihydro-n-(8-methyl-8-azabicyclo[3.2.1.]oct-3-yl)-2-oxo-1h-benzimidazole-1-carboxamide hydrochloride monohydrate |
01/29/2004 | WO2004009586A1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders |
01/29/2004 | WO2004009585A2 Acyloxypyrrolidine derivatives and use thereof as ligands of v1b or both v1b and v1a receptors |
01/29/2004 | WO2004009563A1 5-aryltetrazole compounds, compositions thereof, and uses therefor |
01/29/2004 | WO2004009562A1 Substituted triazine kinase inhibitors |
01/29/2004 | WO2004009548A1 1-heterocyclylalkyl-3-sulfonylindole or -indazole derivatives as 5-hydroxytryptamine-6 ligands |
01/29/2004 | WO2004009547A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
01/29/2004 | WO2004009546A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
01/29/2004 | WO2004009544A1 2-cyano-4-fluoropyrrolidine derivative or its salt |
01/29/2004 | WO2004009036A2 Compounds compositions and methods |
01/29/2004 | WO2004008859A1 Fused-benzene derivatives of thiouracil, herbicidal and desiccant compositions contaning them |
01/29/2004 | WO2004008837A2 Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them |
01/29/2004 | WO2003072572A8 Beta3-adrenergic receptor agonists |
01/29/2004 | WO2003053366A3 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
01/29/2004 | WO2003000180A3 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
01/29/2004 | US20040019208 5-Aryltetrazole Compounds, compositions thereof, and uses therefor |
01/29/2004 | US20040019190 Thrombopoietin mimetics |
01/29/2004 | US20040019093 Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them |
01/29/2004 | US20040019092 Non-peptide somatostatin receptor ligands |
01/29/2004 | US20040019091 Cholecystokinin receptor agonists; antiobesity agents |
01/29/2004 | US20040019083 Amino acid derivatives; antineoplastic agents |
01/29/2004 | US20040019058 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
01/29/2004 | US20040019050 Selective NPY (Y5) antagonists (triazines) |
01/29/2004 | US20040019049 Substituted quinazolinone compounds |
01/29/2004 | US20040019046 Phenylacetamido-pyrazole derivatives and their use as antitumor agents |
01/29/2004 | US20040019045 Pyrazole compounds as anti-inflammatory and analgesic agents |
01/29/2004 | US20040019038 Compounds useful as anti-inflammatory agents |
01/29/2004 | US20040019037 E.g.,((5-(2,4-Diaminopyrimidin-6-yl)pentanoyl)-(N-methyl)amino )-3-(6-meth-oxypyridin-3-yl)-propanoic acid, inhibition of bone resorption, restenosis, angiogenesis inhibitors, antiarthritic, -tumor, -carcinogenic agents; antidiabetic |
01/29/2004 | US20040019033 Mandelic acid derivatives and their use as throbin inhibitors |
01/29/2004 | US20040019015 Administering an effective amount of a protein tyrosine kinase inhibitor (containing first and second module) to the patient to protect against or to treat hearing loss |
01/29/2004 | US20040018986 Viricide against hepatitis virus |
01/29/2004 | US20040018942 Herbicides; controlling weeds |
01/29/2004 | US20040018941 Applying to plants; synergistic mixture |
01/29/2004 | US20040018192 Integrin expression inhibitors |
01/29/2004 | DE10239612A1 Verfahren und Verbindungen zur Beeinflussung der Raumstruktur von GNB-Proteinen Methods and compounds for influencing the spatial structure of proteins GNB |
01/29/2004 | CA2493721A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
01/29/2004 | CA2493339A1 2-cyano-4-fluoropyrrolidine derivative or salt thereof |
01/29/2004 | CA2492847A1 5-aryltetrazole compounds, compositions thereof, and uses therefor |
01/29/2004 | CA2492224A1 Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutics |
01/29/2004 | CA2492217A1 Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them |
01/29/2004 | CA2491248A1 1-heterocyclylalkyl-3-sulfonylindole or -indazole derivatives as 5-hydroxytryptamine-6 ligands |
01/28/2004 | EP1384717A2 Tetrazolylphenylboronic acid intermediates for the synthesis of A II receptor antagonists |
01/28/2004 | EP1384712A1 Derivatives of N-((quinolinyl)oxy)-phenyl)-urea and N-((quinazolinyl)oxy)-phenyl)-urea with antitumor activity |
01/28/2004 | EP1383760A1 Biarylcarboxamide compounds as apolipoprotein b inhibitors |
01/28/2004 | EP1383759A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity |
01/28/2004 | EP1383747A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
01/28/2004 | EP1383743A2 Dual inhibitors of pde 7 and pde 4 |
01/28/2004 | EP1383506A2 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7 |
01/28/2004 | EP1268479B1 Phenyl-substituted indolizine derivatives and their use as histamine h3 ligands |
01/28/2004 | EP1143946B1 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
01/28/2004 | CN1471535A Tricyclic derivatives of indole with antiangiogenic activity |
01/28/2004 | CN1471525A Triazole derivatives and pharmaceutical compounds comprising them |
01/28/2004 | CN1471511A Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
01/28/2004 | CN1471394A Tripeptidyl peptidase inhibitors |
01/28/2004 | CN1136217C 4-aryloxindoles as inhibitor of JNK protein kinases |
01/28/2004 | CN1136198C Novel benzyl pyrimidines |
01/27/2004 | US6683215 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
01/27/2004 | US6683191 Preparing a azole compound on a solid support resin, cleaving the compound from the solid support resin by nucleophilic substitution to further substituting by alkylation reaction |
01/27/2004 | US6683189 Method for the synthesis of pyrrole and imidazole carboxamides on a solid support |
01/27/2004 | US6683176 Intermediates for and synthesis of 3-methylene cephams |
01/27/2004 | US6683106 Reduced side effects; efficacy |